Aurobindo Pharma Surges Over 4%, Hits 52-Week High

Aurobindo Pharma shares surged as much as 5 per cent to hit 52-week high of Rs 1,462.80 on the National Stock Exchange.   Including today's gain the stock has surged around 14 per cent in last seven trading sessions after the company said that it had received final approval from the US Food & Drug Administration (US FDA) to manufacture and market extended Phenytoin sodium capsules, which is an anti-epileptic drug used for controlling...